Aditya Bagrodia, MD, is a board-certified urologist who specializes in detecting, treating and preventing genitourinary cancer. He is experienced in surgical and nonsurgical treatments for all urologic malignancies, including adrenal, upper tract, renal, bladder, prostate, penile and testicular cancers. He also has expertise in minimally invasive approaches to urologic surgery.

As an associate professor in the Department of Urology, Bagrodia trains medical students, residents and fellows at UC San Diego School of Medicine, where he leads the genitourinary disease team. He has focused his clinical and research interests on understanding molecular attributes of germ cell tumors, which cause testicular cancer, with the goal of ultimately improving treatments and clinical care. He also has been actively involved in understanding and overcoming societal and epidemiological barriers to optimal care in testicular cancer patients.

Bagrodia has been involved in clinical trials for patients with testicular cancer and has conducted extensive research in urologic oncology, primarily in biomarker profiles and molecular signatures of urologic tumors as predictors of clinical outcomes. He has been funded through intramural research grants and also via competitive grants from the Cancer Prevention and Research Institute of Texas (CPRIT) and the National Institutes of Health.

No Research/Citations

New Technology Illuminates Bladder Cancer Detection

New UC San Diego Health bladder cancer detection procedure uses blue light and imaging dye to make cancer cells glow pink in clinic and operating room settings.
28-Mar-2023 10:05:29 AM EDT

No Quotes

Available for logged-in users onlyLogin HereorRegister

No Video